Carle Cancer Institute is the premier cancer treatment and support center in east central Illinois, offering more resources to help patients in the fight against cancer. With the area's largest and most specialized team of fellowship trained oncologists, surgeons and staff, patients get in for diagnosis and start treatment as soon as possible. Our team offers the latest technology and highly specialized multidisciplinary clinics for certain cancers, including breast, prostate, gynecologic, and head and neck. But we don't just treat a disease – we care for the whole patient, offering support groups, genetic and nutrition counseling, nurse navigator services and more.
Our experts in oncology, breast imaging, reconstructive surgery, genetics, research and support services, give you the tools you need in the fight against breast cancer.
With a team approach to care, experts at Carle Cancer Institute develop an individualized plan of treatment for patients with gastrointestinal cancer.
Carle gynecologic oncology team serves women who have or are suspected of having ovarian, cervical, endometrial, and vulvar cancers.
The Carle Cancer Institute focuses on aggressive and effective treatment, helping to instill hope in patients undergoing what is often an unknown journey.
With a team approach to care, experts at Carle Cancer Institute develop an individualized plan of treatment for patients with lung cancer.
With a team approach to care, experts at Carle Cancer Center develop an individualized plan of treatment for patients with lymphoma and leukemia.
Experts at Carle Cancer Institute along with Dermatology and Plastic Surgery experts develop and individualized plan for patients with skin cancer.
Our urologic cancer practice is based on a multi-specialty approach that combines clinical expertise from urology and radiation oncology.
Have a patient referral? Refer a patient now.
Involved in national research for more than 30 years, Carle Cancer Institute offers its patients access to innovative ways to fight cancer through clinical trials. Clinical trials offer new insight into how to combat a disease like cancer and demonstrate new ways of preventing, treating, or possibly curing cancer.
Carle Cancer Institute provides access to clinical trials for several types of cancer including but not limited to breast, lung, colon, melanoma, prostate, and ovarian cancer. We are also actively involved in national prevention clinical trials per cancer type. In addition, we offer symptom management program to address the quality of life of cancer patients.
This randomized phase II trial studies how well trastuzumab and pertuzumab work compared to cetuximab and irinotecan hydrochloride in treating patients with HER2/neu amplified colorectal cancer that has spread from where it started to other places in the body and cannot be removed by surgery. Monoclonal antibodies, such as trastuzumab and pertuzumab, may interfere with the ability of tumor cells to grow and spread. Drugs used in chemotherapy, such as cetuximab and irinotecan hydrochloride, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving trastuzumab and pertuzumab may work better compared to cetuximab and irinotecan hydrochloride in treating patients with colorectal cancer.
This phase III trial studies how well tenofovir alafenamide works in preventing liver complications in participants with current or past hepatitis B virus (HBV) who are receiving anti-cancer therapy for solid tumors. People with chronic or past HBV who are undergoing therapy for cancer are at an increased risk for changes in the liver which could be minor or severe. Tenofovir alafenamide is a drug that acts against infections caused by HBV and may help reduce the chance that HBV gets worse or comes back in participants receiving anti-cancer therapy for solid tumors.
This randomized phase II trial studies how well carboplatin and paclitaxel with or without ramucirumab work in treating patients with thymic cancer that has spread to other places in the body, has come back, or cannot be removed by surgery. Drugs used in chemotherapy, such as carboplatin and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Monoclonal antibodies, such as ramucirumab, may interfere with the ability of tumor cells to grow and spread. It is not yet known if giving carboplatin and paclitaxel with or without ramucirumab will work better in treating patients with thymic cancer.
With doctors practicing in 80 specialties at locations throughout the region, it’s easy to find the right healthcare team at Carle. Our mission is to serve people through high quality care, medical research and education.
Charitable gifts are used for numerous projects and programs that enhance the healthcare experience for cancer patients and their loved ones. With your support, we’ll continue to work to eliminate cancer through excellence in diagnosis, treatment, research and education.
Recognized among the nation’s top hospitals, Carle provides excellent healthcare while continuously improving to meet the needs of our patients.